Class II HLA interactions modulate genetic risk for multiple sclerosis
Crossref DOI link: https://doi.org/10.1038/ng.3395
Published Online: 2015-09-07
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Text and Data Mining valid from 2015-09-07
Article History
Received: 13 January 2015
Accepted: 12 August 2015
First Online: 7 September 2015
Competing interests
: A.T.D., P.D., S.L. and G.M. are partners in Peptide Groove, LLP, which commercializes HLA*IMP.